Skin & Allergy News Digital Network Launches Product Zone

By Elsevier, PRNE
Sunday, August 1, 2010

MORRISTOWN, New Jersey, August 2, 2010 - Skin & Allergy News Digital Network, a part of International Medical News
Group, LLC, an Elsevier company, announces the launch of Product Zone on its
site, www.skinandallergynews.com. Product Zone is a targeted product
and digital resource center designed to assist dermatologists, physicians,
and related healthcare professionals in making informed purchasing decisions.
This new resource will provide immediate and comprehensive access to critical
information used in the medical buying process, including videos, white
papers, webcasts, case studies, and additional content delivered in more than
20 digital formats. The new Product Zone launches with more than 4,000
product, company and resource listings devoted exclusively to the dermatology
market.

"The medical purchasing process is becoming increasingly complex as
buyers are relying more and more on a variety of online information sources
including vendor content, digital resources, and independent research," said
Alan Imhoff, President of International Medical News Group (IMNG). "We
launched the new Product Zone to provide the most extensive information
resource of its type. No other dermatology product information resource
features this scope and depth. Along with the Product Zone, we will also
announce a new series of online media programs to help our advertisers
educate their prospects and establish leadership positions within their
product categories as well as qualify validated sales leads."

The online Product Zone is a partnership between IMNG and Pure Incubation
and is powered by the technologies and web content resources at
www.MedicalProductGuide.com. "We are excited to have the opportunity
to create the most comprehensive buying resource for the dermatology market,"
said Melissa Chang, President and Founder of Pure Incubation.

For more information on Product Zone or Skin & Allergy News Digital
Network, please visit www.skinandallergynews.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).

About Pure Incubation

Pure Incubation is an industry leader in powering the social buying
process for Healthcare and Technology markets, located in Topsfield, MA. The
company specializes in developing data driven web properties and performance
media programs that are focused exclusively on the product buying process.
Founded by Internet Media veterans, Pure Incubation develops proprietary
technologies (www.SauceTechnology.com) to manage its own media
properties (www.MedicalProductGuide.com and
www.EnterpriseGuide.com) and powers web properties via exclusive
partnerships with industry leaders in their respective specialty markets.

    Media Contact:
    Jennifer Eckert
    Phone +973-290-8235
    E-mail j.eckert@elsevier.com

Media Contact: Jennifer Eckert, Phone +973-290-8235, E-mail j.eckert at elsevier.com .

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :